Oklahoma AG Announces $17.85M Settlement with Drug Companies Over Price-Fixing

The settlement will allow Oklahomans who purchased certain generic drugs between 2009-2019 to qualify for compensation.

Published on Feb. 6, 2026

Got story updates? Submit your updates here. ›

Oklahoma Attorney General Gentner Drummond's office announced a $17.85 million settlement with Lannett Company, Inc. and Bausch Health companies over allegations of price-fixing on generic drugs. The settlement will allow Oklahomans who purchased certain generic prescription drugs between May 2009 and December 2019 to qualify for monetary compensation.

Why it matters

The alleged price-fixing by these pharmaceutical companies cost Oklahoma consumers and state healthcare programs millions of dollars. This settlement holds the companies accountable and provides compensation to affected Oklahomans.

The details

The settlement resolves allegations that Lannett Company, Inc. and Bausch Health companies illegally colluded to inflate prices on a variety of generic drugs, including antibiotics, antidepressants, contraceptives, and non-steroidal anti-inflammatory drugs in the form of tablets, capsules, creams, and ointments.

  • The alleged price-fixing occurred between May 2009 and December 2019.
  • The settlement was announced on February 6, 2026.

The players

Gentner Drummond

The Attorney General of Oklahoma who announced the $17.85 million settlement.

Lannett Company, Inc.

One of the pharmaceutical companies accused of price-fixing on generic drugs and that reached a settlement with the Oklahoma Attorney General's office.

Bausch Health companies

One of the pharmaceutical companies accused of price-fixing on generic drugs and that reached a settlement with the Oklahoma Attorney General's office.

Got photos? Submit your photos here. ›

What they’re saying

“These drug companies colluded to jack up prices on medications that Oklahoma families depend on. Their illegal scheming cost our citizens and state healthcare programs millions of dollars. We're holding them accountable and will continue fighting to protect Oklahoma consumers.”

— Gentner Drummond, Attorney General of Oklahoma (KFOR)

What’s next

Oklahomans who purchased certain generic prescription drugs between May 2009 and December 2019 may be eligible for compensation through the settlement. The Attorney General's office will provide details on the claims process.

The takeaway

This settlement demonstrates the Oklahoma Attorney General's commitment to holding pharmaceutical companies accountable for anti-competitive practices that harm consumers. It provides financial relief to Oklahomans affected by the alleged price-fixing scheme.